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UncouplingHeart failure constitutes a major public health problem worldwide. Affected patients experience a number of
changes in the electrical function of the heart that predispose to potentially lethal cardiac arrhythmias. Due to
themultitude of electrophysiological changes that may occur during heart failure, the scientiﬁc literature is com-
plex and sometimes ambiguous, perhaps because these ﬁndings are highly dependent on the etiology, the stage
of heart failure, and the experimental model used to study these changes. Nevertheless, a number of common
features of failing hearts have been documented. Prolongation of the action potential (AP) involving ion channel
remodeling and alterations in calcium handling have been established as the hallmark characteristics of
myocytes isolated from failing hearts. Intercellular uncoupling andﬁbrosis are identiﬁed asmajor arrhythmogen-
ic factors.
Multi-scale computational simulations are a powerful tool that complements experimental and clinical research.
The development of biophysically detailed computer models of single myocytes and cardiac tissues has contrib-
uted greatly to our understanding of processes underlying excitation and repolarization in the heart. The electri-
cal, structural, and metabolic remodeling that arises in cardiac tissues during heart failure has been addressed
from different computational perspectives to further understand the arrhythmogenic substrate.
This review summarizes the contributions from computational modeling and simulation to predict the underly-
ing mechanisms of heart failure phenotypes and their implications for arrhythmogenesis, ranging from the cel-
lular level to whole-heart simulations. The main aspects of heart failure are presented in several related
sections. An overview of the main electrophysiological and structural changes that have been observed experi-
mentally in failing hearts is followed by the description and discussion of the simulation work in this ﬁeld at
the cellular level, and then in 2D and 3D cardiac structures. The implications for arrhythmogenesis in heart failure
are also discussed including therapeutic measures, such as drug effects and cardiac resynchronization therapy.
Finally, the future challenges in heart failure modeling and simulation will be discussed.
© 2015 The Authors. Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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The deﬁnition of heart failure (HF) is still changing and evolving. In-
deed, deﬁnitions of heart failure depend on the contexts in which this
term is used, but it is generally considered a syndrome in which the
pumping action of the heart fails to provide sufﬁcient amount of blood
and oxygen to the organs, including the heart itself [1]. HF is the ﬁnal
common pathway of various cardiac pathologies such asmyocardial in-
farction, hypertrophy, congenital cardiac abnormalities, valve disease,
hypertension, dilated cardiomyopathy, and tachycardia-dependent car-
diomyopathy. The primary electrophysiological changes and the mech-
anisms of arrhythmogenesis associated with HF depend on the etiology
[2]. However, there are some common features, which are described in
this section.
At the cellular level, there is a prolongation of the action potential,
resulting from the remodeling of some ion currents, such as the late so-
dium current (INaL) [4,5] which is signiﬁcantly enhanced. Also, reduc-
tions of the inward rectiﬁer K+ current (IK1), the transient outwart K+
current (Ito), and theNa+/K+pump (INaK) [3] have been experimentally
measured. The increased INaL and elevated cytosolic Na+ ([Na+]i) in HF
is linked to the cellular Ca2+ overload via the Na+–Ca2+ exchanger
(NCX) [6]. NCX activity is critically regulated by [Na+]i, and even amod-
est increase in [Na+]i causes a decrease in the exchanger to extrude less
Ca2+, raising the cellular Ca2+ content [7,6]. Also upregulation of the
NCX in HF may magnify the functional impact of altered [Na+]i, and
thus Ca2+ overload. Alterations in calcium handling, i.e. an increase of
diastolic [Ca2+]i, a decrease of systolic [Ca2+]i peak, and a slow
[Ca2+]i decay, as well as intracellular sodium accumulation, have been
established as the hallmark characteristics of myocytes and tissues iso-
lated from failing hearts, especially in terminal HF [8–10]. Detubulation
and changes in the beta adrenergic system have also been observed in
failing hearts and have been related to the abovementioned alterations
of Ca2+ transients [11,12].
Animal studies [13,14] have shown that the gap junctional protein
connexin43 (Cx43) is redistributed from the intercalated disk to the
lateral ventricular myocyte borders and that the amount of hypo-
phosphorylated Cx43 is increased, leading to intercellular uncoupling
and reduced conduction velocity in HF [15,16]. In addition, remodeling
of the extracellular matrix including the presence of cardiac myo-
ﬁbroblasts [17–20] and their interactions with cardiomyocytes, alters
electrical conduction, which is determinant in HF arrhythmogenesis.
During HF, electrophysiological remodeling and Ca2+-handling
alterations can lead to focal activity initiated by either early
afterdepolarizations (EADs) or delayed afterdepolarizations (DADs),
thatmay lead to a triggered premature beat [2]. If the alteredmyocardi-
al structure represents a suitable substrate, characterized by repolariza-
tion heterogeneities, ﬁbrosis and/or uncoupling, reentry may ensue.
Reentrant rhythms have been observed in failing hearts and an im-
proved understanding of the responsible mechanisms is much needed.
The complexity and variability of the experimental and clinical stud-
ies performed to characterize the HF pathology justify the need of fur-
ther assistance to fully understand HF etiology and the underlying
arrhythmogenic mechanisms. Computer models emerge as a comple-
mentary and very effective tool to ﬁll this gap. Indeed, personalized
multi-scale models are able to establish the link between the cellular
or even genetic or molecular changes during disease and the conse-
quent arrhythmogenicmechanisms. Simulation studies allow also com-
ponent dissection, which is hardly feasible in experiments or in clinicalenvironments, and enrich our understanding of these complex
mechanisms.
2. Computational modeling of heart failure at the cellular level
2.1. Electrophysiological remodeling and altered Ca2+ handling
Multiple electrophysiological changes have been experimentally ob-
served in isolated failing cardiac cells. Computational models have
helped to analyze the cellular electrophysiological consequences of
these changes. The ﬁrst simulation study that focused on heart failure
induced electrical alterations (at the cellular level) was carried out by
Priebe and Beuckelmann in 1998 [21]. In this work, the AP of a human
ventricular myocyte was modeled and modiﬁed to simulate HF. Select-
ed ion currents (see Table 1), based on experimental data, were
remodeled leading to HF phenotype, characterized by a longer action
potential duration (APD) and a corresponding altered Ca2+ transient.
Priebe and Beuckelmann [21] also showed that EADs could develop in
HF conditions following the block of the rapid delayed K+ current
(IKr). They used themodel results to propose how spontaneous calcium
release triggered a premature AP in HF; the reduction of repolarization
currents (IK1 and INaK) rather than an increase of the depolarizing cur-
rent (INaCa) seemed to be responsible for the enhanced likelihood of
triggered APs in failing myocytes. Because the effects of altered Ca2+
transients in HF are widely suggested to be critical for proarrhythmic
phenomenon, a number of models have since been developed that de-
scribe in detail the behavior of intracellular calcium pathways.
Since the ﬁrst study, a number of computational works have focused
on describingHF phenotype on the basis of newemerging experimental
data. Table 1 summarizes the HF computational models that have been
developed to date. As shown in Fig. 1, several computational models re-
produce not only APD prolongation, but also elevated diastolic [Ca2+]i
levels, the reduction of peak systolic [Ca2+]i and the slow decay of
Ca2+ transient observed experimentally in failing cells [22,23]. Speciﬁ-
cally, Winslow et al. [24] deﬁned the minimum model of ‘end-stage
heart failure’ focusing on the protein levels of SR Ca+2 ATPase and
NCX in canine cardiac ventricular failing myocytes. The model estimat-
ed a range for NCX upregulation and SERCA pump downregulation re-
sponsible for altered Ca2+ transients.
Using a similar approach, Puglisi et al. [25] developed a computa-
tional model to analyze the electrophysiological and Ca2+ transport
properties of failing rabbit ventricular myocytes. They showed that
combining enhanced Na+/Ca2+ exchange with reduced IK1 (as occurs
in HF) lowers the [Ca2+]i threshold to trigger an AP.
A more detailed description of Ca2+ dynamics was developed by
Shannon et al. [26], who predicted that increased Ca2+ afﬁnity of the
ryanodine receptors (RyR) increased the probability of delayed
afterdepolarizations (DADs) when heart failure was simulated. Calcium
calmodulin kinase II (CaMKII) pathway, another important factor for
Ca2+ dynamics especially in HF, was recently introduced in AP models
[27–29]. CaMKII is upregulated in HF and strongly affects Ca2+ han-
dling. CaMKII shifts sodium current availability to more negative volt-
ages, enhances intermediate inactivation, and slows recovery from
inactivation, but also enhances the activity of the INaL. CaMKII also in-
creases Ca2+ and K+ currents (ICa and Ito). CaMKII-induced alterations
of sodium current (INa), Ca2+ current (ICa), and transient outward K+
current (Ito) weremodeled by Grandi et al. [29] to analyze the complex-
ity of CaMKII-dependent AP changes. Simulation results showed a
Table 1
Electrophysiological characteristics in computational models of heart failure. The percentage of increase (↑) or decrease (↓) of ion currents are indicated with respect to the original and
physiological normal corresponding action potential model. In the case ofWalmsley et al. study downregulation of a parameter is sampled in the range−60% to 0% change from the orig-
inal parameter values (ORd model) and upregulation is sampled from 0 to+60% change from the original parameter values. The modiﬁed parameters are: the fast sodium current (INa),
the late Na+ current (INaL), the time constant of inactivation gate of the INaL (τhL), the L-type calcium channel current (ICaL), the transient outward K+ current (Ito), the rapid delayed rec-
tiﬁer potassium current (IKr), the slow delayed rectiﬁer potassium current (IKs), the Na+/Ca2+ exchanger (INCX), the inward rectiﬁer K+ current (IK1), theNa+/K+ pump current (INaK), the
sarcoplasmic reticulum (SR) Ca2+ pump (Iup/JSERCA), the SR Ca2+ leak current (ILeak), the background Na+ current (INab), and the background Ca2+ current (ICab).
HF simulation models Species INa INaL τ(NaL) ICaL Ito IKr IKs INCX IK1 INaK Iup/Jserca ILeak INab ICab
Winslow et al. [24] Dog ↑104% ↓28%
Winslow et al. [38] Dog ↓66% ↑75% ↓33% ↓68%
Puglisi et al. [25] Rabbit ↓36% ↑100% ↓49% ↓24%
Shannon et al. [26] Rabbit ↑100% ↓50%
Morita et al. [39] Rabbit ↑200% ↑200% ↓20%
Priebe and
Beuckelmann [21]
Human ↑65% ↓25% ↓42% ↓66% ↓65%
Zhang et al.
[34]
Human ↓57% ↑1200% ↑200% ↓36% ↓? ↑65% ↓25% ↓42% ↓?
Narayan et al. [40] Human ↓25–200% ↓25–200%
Zlochiver [32] Human ↓34% ↓36% ↓50% ↑36% ↓43%
Moreno et al. [41] Human ↑250% ↓36% ↑65% ↓25% ↓36% ↓31%
Lu et al.
[30]
Human ↓40% ↓64% ↓50% ↑65% ↓20% ↓42% ↓45% = ↑53%
Trenor et al. [35] Human ↑200% ↑200% ↓40% ↑75% ↓32% ↓10% ↓50% ↑500% =0 ↑53%
Moreno et al. [31] Human ↑1000% ↓36% ↓25% ↓10–42% ↓36% ↑350% ↑1600%
Walsmsley et al. [37] Human ↓ (0–60%) ↓ (0–60%) ↓ (0–60%) = ↑ (0–60%) = ↓ (0–60%)
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ing for CaMKII-induced Ito increase. Combining the effects of CaMKII-
induced changes on different currents (INa, ICa and Ito) led to APD short-
ening. Furthermore, transmural heterogeneity in Ito, its downregulation
in HF, and CaMKII-induced changes in this current may accentuate dis-
persion of repolarization. These simulation studies suggest potential
pathways by which CaMKII may contribute to arrhythmogenesis.
Also, the development of an advanced coupled model integrating
the spatiotemporal Ca2+ reaction–diffusion system into the cellular
electrophysiological model by Lu et al. [30] revealed that the presence
of rogue RyRs (non-clustered RyRs) destabilized Ca2+ dynamics, lead-
ing to the spontaneous initiation of Ca2+ waves. These pathological
waves led to the generation of DADs or triggered action potentials in HF.
A further step in the simulation of HFwas taken byMoreno et al. [31]
by including the β-adrenergic signaling pathway in a computational
work. The β-adrenergic pathway in the model includes CaMKII and
PKA signaling, important regulatory pathways shown to be upregulated
in human heart failure. They showed that overactive β-adrenergic acti-
vation resulted in increased INaL and elevated intracellular Na+ that
cause an increase in [Ca]i via NCX and ultimately electrical instabilities
e.g. DADs, and beat-to-beat variability in APD.
Computer models of HF have also helped to understand how HF al-
ters cellular excitability. Zlochiver et al. [32] employed the ten Tusscher
et al. [33] model to demonstrate that higher stimulation currentmagni-
tudes were needed for excitation of the failing tissue, as well as larger
stimulation areas. This reduction of excitability was attributed to IK1 re-
modeling in HF. This study also showed the non-linear effect of ﬁbrosis
on tissue excitability, highlighting the complexity of subthreshold exci-
tation properties in thediseasedmyocardium,which strongly affects ec-
topic foci-originated arrhythmias and determines the efﬁcient design of
stimulating electrodes.
The experimentally reported ranges for electrophysiological (EP)
changes at the cellular level, as well as the extent of changes in ion
channels, transporters and overall remodeling, vary substantially for
different experimental settings and HF stages. Therefore, taking into ac-
count the available literature, a sensitivity analysis aimed at assessing
the impact of the main ionic parameters remodeled in HF was per-
formed by Trenor et al. [35]. The ranges of remodeling considered in
this study for the different ionic parameters in HF led to changes in AP
and Ca2+-handling biomarkers within experimental observations. Sim-
ulation results revealed the important role of INaL in the prolongation ofAPD, in the triangulation of the shape of the AP, and in the changes of
Ca2+ transient in failing conditions.
Although considerable research has been devoted to the effect of al-
tered channel function in the failing heart, less attention has been paid
to mRNA expression channel levels [36]. Functional ion channel activity
is not always directly related with protein expression levels in the cell
membrane, but it may be related. In this respect, the work of Walmsley
et al. [37] focused on the role that mRNA expression levels may play in
the electrophysiological changes in human HF. This work takes into ac-
count this variability by deﬁning a population of models for HF using
mRNA data obtained from failing and nonfailing human hearts. Simula-
tions revealed that changes in AP biomarkers were drivenmainly by IKr,
while changes on calcium transient biomarkers were due to ICaL and
SERCA pump. Caution should be taken in the interpretation of these re-
sults, as the downregulation of ICaL is controversial in the human failing
heart.
2.2. Increased late sodium current (INaL) in heart failure
Experimental approaches and computational modeling are comple-
mentary methods for assessing how abnormalities in sodium behavior
at the cellular level can lead to arrhythmias in the whole heart [42].
INaL has been recognized as one of the major factors contributing to ab-
normal repolarization in HF [43–46].
The enhancement of INaL in failinghumanhearts as compared to nor-
mal hearts has been measured by several experimental groups [4,5].
However, INaL was rarely included in the basic formulation of APmodels
developed for control conditions. In the last decade, substantial im-
provements in AP models have been made and this current has been
modeled using both Markov models and Hodgkin Huxley formulations.
INaL has been added to existing AP models for different animal species
[29,31,35,47–50]. Hund et al. [50] included a formulation for the INaL
in a canine cardiac ventricular AP model. Trenor et al. [35] adapted
this formulation with the available experimental human data to repro-
duce the failingphenotype and included it in theGrandi et al., humanAP
model [51]. Themost recent AP humanmodel includes this formulation
for control conditions [52].
The consideration of INaL in computational models of heart failure is
crucial in simulating the activity of failing ventricular cells because of its
important role in repolarization abnormalities, such as EAD generation
[31,32,34,35,41,53]. Model predictions have suggested INaL as a novel
Fig. 1. Electrophysiological changes in heart failure. Simulated action potentials (APs) (left panels) and Ca2+ transients (right panels) obtained in normal conditions and after heart failure
electrophysiological remodeling. Panels A and B, C and D, and E and F illustrate the simulations carried out by Winslow et al. [24], Zhang et al. [34], and Trenor et al. [35], respectively.
Reproduced with permission from [24].
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such as DADs generation [54]. Indeed, computational studies have con-
tributed to the understanding of the close relationship between Ca2+
dynamics and Na+ ﬂuxes, showing that increased intracellular Na+
and increased INaL in the failingmyocardium contribute to the alteration
of Ca2+ load [42]. Although INaL increase contributes to the [Na+]i accu-
mulation reported in HF, computational studies have challenged the no-
tion that INaL is the unique responsible. Indeed, INaL enhancement
caused by CaMKII activation is not quantitatively sufﬁcient to account
for the [Na+]i elevation observed in HF [54–56] (see Grandi and Herren
2014 for review [57]). Furthermore, the existence of a diastolic leak Na+
inﬂux in human failing myocytes has been suggested to signiﬁcantly
contribute to [Na+]i elevation [54], as well as an increased activity of
INCX and Na+/H+ exchanger promoted by acidosis [58,59].2.3. Changes in T-tubules and cellular size in HF
It is now well-known that loss and/or disruption of T-tubules may
occur in failing ventricular myocytes [12,60,61], contributing to
dyssynchronous calcium release and impaired contraction. T-tubule dis-
ruption removes the L-type Ca2+ channels (LCC) from the associated
Ca2+ release units and results in “orphaned” RyR clusters. In addition,
loss of T-tubules leads to a redistribution of β2-adrenergic receptors
(β2ARs) from T-tubules to detubulated membrane areas, especially af-
fecting Ca2+ transients [62]. Indeed, it is well-known that the β1- and
β2-adrenergic receptors (βARs) regulate the production of the second
messenger cyclic adenosine monophosphate (cAMP). β2ARs are spa-
tially conﬁned in the T-tubules, and its stimulation is cardioprotective,
whereas β1ARs are distributed across the entire cell surface and its
150 J.F. Gomez et al. / Journal of Molecular and Cellular Cardiology 89 (2015) 146–159chronic stimulation promotes hypertrophy and apoptosis [62,63]. The
redistribution of β2ARs from the T-tubules to the cell crest in HF is re-
sponsible for the loss of the normally cardioprotective properties of
β2AR signaling, which may acquire the characteristics of the β1AR re-
sponse [62]. The propagating β2AR-cAMP gradients observed in failing
cardiomyocytes induces phospholamban and troponin I phosphoryla-
tion [62,64], which is associated with arrhythmogenic effects, by
increasing the serca pump activity and Ca2+ SR load [64]. Thus, the re-
distribution of β2ARs in HF changes compartmentation of cAMP and
might contribute to the failing myocardial phenotype.
It is also important to highlight the T-tubule localization of the inward
rectiﬁer K+ channels [65]. Indeed, detubulation has been shown to de-
crease IK1 activity [66], which could have important consequences for
membrane resting potential. The mechanisms by which detubulation
disrupts the electrical activity in the failing heart are poorly understood
and is an area in which computer simulations can deﬁnitely help.
In ventricular cardiomyocytes, calcium release occurs at distinct
structures (dyads) along T-tubules. Only a few simulation studies have
thus far modeled detubulation in the failing heart. Gaur et al. [67] devel-
oped amodel of Ca2+ cyclingwhich takes into account local dyadic Ca2+
release activities and interactions between dyads via Ca2+ diffusion.
Under failing conditions, simulated as increased dyadic volume and re-
duced LCC/RyR relation, SR Ca2+ release becomes dyssynchronous and
interdyad coupling serves as a compensatory mechanism that improves
synchrony. These simulations provided insight into Ca2+ waves genera-
tion via calsequestrin interaction; the impaired function of this calcium
sensor lead to diastolic Ca2+ accumulation and subsequent Ca2+ release
events. Also in the combined experimental and simulationwork of Louch
et al. [68] the dyssynchronous Ca+2 release is attributed to T-tubule
reorganization.
Alternans were also simulated in a computational HF cellular model
promoted by detubulation [69]. Similarly, Wright et al. [70] simulated
detubulation and highlighted the role of altered β2AR and cAMP signal-
ing in failing cardiomyocytes. Including detubulation in cellular models
of HF may be important in order to fully represent Ca2+ transient
alterations.
Another important change observed in failing hearts is an increase of
the cell size. The loss of contractile function is compensated by cardiac
hypertrophy [2]. Patients with HF have an increased QRS duration,
which cannot be attributed to decreased conduction velocity only, but
also to an increase of myocyte size. Wiegerinck and coworkers carried
out a set of simulations focused on the effect of hypertrophiedmyocytes
[71] and found that although conduction velocity was increased, the
larger cell size led to QRS prolongation. These simulations predicted a
novel mechanism of conduction slowing in HF and also suggested the
importance of considering cell size in HF models.
2.4. β-Adrenergic stimulation in HF
The β-adrenergic signaling pathway regulates cardiac myocyte con-
tractility, which is impaired in the failing heart. Increased sympathetic
activity is a hallmark of HF and β-blockers appear to reduce mortality
in these patients [72], although the mechanisms responsible are not
completely understood. Detailed electrophysiological models have be-
come helpful in understanding complex β-adrenergic cell signaling
pathway and its effects during HF.
β-adrenergic signaling and stimulation are included in severalmodels
of electrical activity of the cardiac cell (see table in pages 9 through 11 in
the SupportingMaterial of Heijman et al. [73]). Themodeling approaches
include either parameter-shifts, i.e. selected conductances of ion channels
or the voltage dependence of several ion channel gates aremodiﬁed byβ-
adrenergic stimulation, or population-based, i.e. a portion of selected ion
channel population is altered by β-adrenergic stimulation. Saucerman
et al. [74] developed a detailed parameter-shift model of the β-
adrenergic signaling pathway for rat ventricular myocytes considering
that altered β-adrenergic signaling may also play an important role inthe progression of HF. Their simulation results suggested that phosphor-
ylation of the L-type calcium channel and phospholamban are sufﬁcient
to predict the dominant changes inmyocyte contractility. They improved
this model by adding interactions of the protein Kinase A (PKA) with
other ion channels, such as IKs to investigate how a genemutation related
with a long-QT syndrome may lead to ventricular arrhythmia during
sympathetic stimulation [75].
The inclusion of CaMKII pathway combined with β-adrenergic acti-
vation of PKA to study excitation-contraction coupling under normal
and failing conditions (CaMKII overexpression) was later studied by
Soltis and Saucerman [76]. Themodel demonstrates how overall chang-
es to calcium handling during CaMKII overexpression are explained by
interactions between individual CaMKII substrates and identiﬁes
CaMKII-dependent ryanodine receptor hyperphosphorylation as a
proarrhythmogenic trigger. Soltis and Saucerman framework was then
adopted by several authors in a mouse AP model [56] and in rabbit AP
models [77,78]. Morotti et al. showed that β-adrenergic stimulation en-
hanced CaMKII activation, potentiating the CaMKII–Na+–Ca2+–CaMKII
feedback in CaMKII overexpressed mice myocytes, and thus increased
the probability of DAD generation. Xie et al. [77,78] slightly modiﬁed
Soltis and Saucerman formulation by establishing different dynamics
of ICaL and IKs increase induced by β-adrenergic stimulation. The faster
increase of ICaL vs IKs upon abrupt β-adrenergic stimulation could ex-
plain the generation of transient EADs [77] and the transient increase
of APD restitution slope, which allows the degeneration of VT into VF
[78].
Recently, the population-based model developed by Heijman et al.
[73] incorporated the effect of CaMKII and β-adrenergic signaling sys-
tems in a multi-compartmental description of protein signaling net-
works for canine ventricular myocytes. The model predicted increased
CaMKII activity during β-adrenergic stimulation due to rate-dependent
accumulation and increased calcium cycling. The inhibition of CaMKII re-
duced compartmentation while selective blockade of β1-adrenergic re-
ceptors reduced the occurrence of DADs. O'Hara et al. [28] used this
model and adapted it for human ventricular AP to analyze the effect of
β-adrenergic stimulation in LQT syndrome. They concluded that with
mutant IKs, β-adrenergic stimulation and IKs partial block favored EAD
generation. AlsoWright et al. [70] usedHeijman et al., [73]model to sim-
ulate detubulation in HF and thus relocation of β2-adrenergic receptors,
which alters the protective effect of β2-adrenergic stimulation. An im-
portant ﬁnding of their study is that caveolin-3 (Cav3) overexpression
can partially restore the disrupted localization of these receptors. It is im-
portant to distinguish between β1AR andβ2AR activity in simulating HF,
because they could have different effects on arrhythmogenesis, as shown
by clinical trials and a number of studies [79–81]. In this way, the model
developed by Bondarenko for mouse myocytes [82] focused on the ef-
fects of β1-adrenergic receptor (β1AR) stimulation and represents an
initial framework for future developments of cellular models for heart
failure. The model elucidates the complex interactions of ionic currents
which ultimately lead to a relative modest increase in APD and signiﬁ-
cant increase in calcium transients when β1AR are stimulated.
While much attention has been paid to β-adrenergic stimulation in
HF progression and to the therapeutic beneﬁts of β-blockers, less inter-
est has been dedicated to the role of α-ARs in the failing heart. Contro-
versial results about the positive inotropic effects of α-ARs stimulation
in humans and detrimental outcome in clinical trials using α-ARs
blockers have deviated the research interest, however, further research
is needed in this respect. To our knowledge, no AP models integrate a
mathematical formulation for the effects of α-ARs stimulation.3. Structural remodeling in virtual failing cardiac tissues
In addition to electrophysiological remodeling, micro- and macro-
anatomical changes, such as intercellular uncoupling and ﬁbrosis, have
been identiﬁed as major arrhythmogenic factors in HF etiology and
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putational studies focused on structural remodeling during HF.
3.1. Consequences of ﬁbrosis derived from computational studies
Fibroblasts are cells of mesenchymal origin that produce intersti-
tial collagen and are responsible for the synthesis and maintenance
of the extra-cellular matrix (ECM), which surrounds and supports
cardiomyocytes. The amount of ﬁbrosis has been measured in the
human heart and reported in experimental studies. Reported values
for normal tissue are 0–2% in tissue from patients with undiseased
hearts. In the setting of documented ventricular ﬁbrillation the amount
of ﬁbrosis increases to 5–20% [83]. In a different study, measurements
taken from human explanted failing hearts yielded 7–43% ﬁbrosis
[84]. These densities are usually given as a percentage of ﬁbrotic area
from the total tissue analyzed. A detailed description of ﬁbroblasts
and the role they play in cardiac tissue is described in the work of
Camelliti and coworkers [85]. The proliferation of ﬁbroblasts in the fail-
ing heart substantially alters its electrical activity [2,44]. Despite the fact
that ﬁbroblasts form a majority cell population in the normal adult
heart, they are electrically unexcitable, but the electrical interaction
with myocytes through gap junction proteins was early observed by
Kohl et al. [86] and corroborated later in several species [18,87,88]
in vitro. However, the presence and extent of ﬁbroblast–myocyte elec-
trotonic coupling in native myocardium (in vivo) remain controversial
[89]. Myocyte-ﬁbroblast interaction is a key factor to a better under-
standing of electrical cardiac propagation in failing hearts.
Detailed ﬁndings concerning the electrophysiological behavior of ﬁ-
broblast membranes are scarce. In this regard, only potassium ionic
channels were found by Chilton et al. [90]. This study provided data
on which an electrophysiological membrane model for mammalian
ventricular ﬁbroblasts was developed by MacCannell and coworkers
[91]. This model includes four membrane currents describing the “ac-
tive” ﬁbroblast membrane potential behavior, and is able to simulate
how myocyte APD is shortened when ﬁbroblasts are coupled. This is
the most widely used model. Another contemporary model developed
by Sachse et al. [92] included a Markovian description of the outward
potassium current. This study examined the impact of ﬁbroblasts on
conduction in one-dimensional strand ofmyocytes, obtaining a reduced
conduction and upstroke velocity. Later, Maleckar et al. [93] adapted
MacCannell's model to simulate the behavior of atrial ﬁbroblasts, show-
ing how myocyte resting potential and AP waveform were modulated
by the properties and number of coupled ﬁbroblast, the degree of cou-
pling, and the pacing frequency. These models have enable the simula-
tion of the electrical activity of 2D and 3D cardiac tissues with ﬁbrosis
and the analysis of the consequences of ﬁbrosis in cardiac electrical
activity.
The ﬁrst computational study simulating electrical coupling between
ﬁbroblasts and myocytes (from sino-atrial node) was performed by
Kohl et al. [86]. The model of the electrotonic interaction of these cells
showed that stretch of the ﬁbroblast during atrial diastole, simulating in-
creased atrial wall tension during atrial ﬁlling, can raise the spontaneous
depolarization rate of the pacemaker cell in a stretch-dependent manner
by up to 24%. The ﬁbroblast was modeled as an electrically passive cell,
the most common description until MacCannell's model formulation
was published [91]. Later, Turner and colleagues [94] simulated ﬁbrotic
content in the ventricle as lines of insulating, unexcitable elements in
the longitudinal and transverse direction. They highlighted the role of ﬁ-
brosis on electrogram fractionation. The results related the effects ofﬁbro-
sis, AP abnormalities and dispersion of AP duration to the characteristic
electrograms recorded in patients at risk of sudden death.
Computer simulations have also helped to interpret how location and
distribution of ﬁbrosis alters cardiac conduction and favors arrhythmias.
Xie et al. [95] developed several conﬁgurations of two dimensional
sheets with ﬁbroblasts and myocytes, showing an increased vulnerabili-
ty to reentrywhen ﬁbroblasts were electrotonically coupled tomyocyteswith respect to tissues where ﬁbroblasts were uncoupled, acting as pure
insulators. The same model was used later to study the formation of
EADs during oxidative stress [39]. They concluded that in aged ventricles
exposed to oxidative stress, ﬁbrosis facilitates the ability of cellular EADs
to emerge and generate trigger activity, ventricular tachycardia, and ven-
tricular ﬁbrillation at the tissue level. EADs generationwas favored by in-
termediate degrees of ﬁbrosis content. Along the same lines, Petrov et al.
[96] showed the inﬂuence of ﬁbrosis on restitution properties and spiral
wave stability in a three-domainmodel approach. Their results predicted
that depending on the value of the resting potential of the cardiac ﬁbro-
blast, the stability of a spiral in tissue may change. Engelman et al. [97]
used a computer model containing non-uniformly distributed barriers
of excitation resembling patchy ﬁbrosis to demonstrate that structural
heterogeneity alone is sufﬁcient to give rise to discordant alternans at
rapid stimulus rates.
Cardiac ﬁbroblasts may act as a “current sink” for connected
myocytes changing cardiomyocyte excitability [98]. Zlochiver et al.
[32] used a numerical model of human cardiac tissue to quantify the
current threshold for atrial and ventricular tissues under diffuse ﬁbrosis
conditions. They concluded that subthreshold excitation properties of
themyocardium, such as current threshold and stimulation area, are in-
ﬂuenced in a non-linear manner by cardiac pathologies such as heart
failure. Later, the same group showed how spiral wave dynamics is al-
tered by the presence of ﬁbroblasts [99]. This study showed that both ﬁ-
broblast density and heterocellular coupling conductance exhibit a
biphasic effect on the frequency of spiral waves and that both impact
the wave stability. Similar results were obtained in the sinoatrial node
by Oren et al. [100] and in ventricular tissue.
Very few simulation studies have focused on the effects of ﬁbrosis in
the setting ofHF. Gomez et al. used computationalmodels to describe var-
iousways bywhich ﬁbrotic content and structural remodelingmodulates
the arrhythmogenic substrate of the failing heart, increasing repolariza-
tion gradients and leading to abnormal impulse propagation [53]. The ﬁ-
brotic content ranged from 4 to 40%, measured as a percentage of nodes
assigned to theﬁbroblast ionicmodel, whichwould correspond to the ex-
perimental ranges in terms of ﬁbrotic area. The vulnerability to reentry
under HF conditions and several degrees of diffuse ﬁbrosis was also
assessed by considering active ﬁbroblast interaction. The results showed
that intermediate degrees of ﬁbrosis (14% and 28%) increased the proba-
bility of reentrant arrhythmias [101]. Similarly, Nayak et al. [102] focused
on the inﬂuence of ﬁbroblast features on spiral-wave control in a 2D
model. They found that the rotation speed and stability of a spiral wave
can be controlled either by the coupling conductance between myocytes
and ﬁbroblasts or by the resting membrane potential of ﬁbroblasts. They
also showed that a spiral wave can get anchored to a local ﬁbroblast inho-
mogeneity. In the same line, thework ofMajumder et al. [103] classiﬁed a
variety of spiral wave non-equilibrium states depending on the percent-
age ofﬁbroblasts. None of these two last studies consideredHF conditions
in their simulations.
The effect of HF on ﬁbroblast ion currents and its potential role in AF
has been addressed recently in the experimental and computational
study by Aguilar et al. [104]. They suggested that ﬁbroblast K+-current
remodeling in HF is a novel component of AF-related remodeling that
might contribute to arrhythmia dynamics.
Finally, other computational studies utilized 3D ventricular models
to simulate the effects of ﬁbrosis at the organ level [103,105]. Similarly
to the results from Gomez et al., they found that intermediate ﬁbrosis
(within experimental ranges) increased vulnerability to arrhythmias
[101]. These simulation results shed light into the mechanisms by
which patients or animal models in moderate stages of HF are more
prone to arrhythmias than patients in the end-stage of HF.
3.2. Simulation of intercellular uncoupling
As stated above, structural remodeling of the failing heart includes
not only proliferation of ﬁbroblasts but also cellular uncoupling. The
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redistributed from an end-to-end to a lateral location in the myocyte
[16,106,107]. This reduction and reorganization gives rise to decreased
conduction velocities in the failing heart [108]. Gima and Rudy have
addressed the effects of cellular uncoupling on AP propagation and con-
duction velocity in thenormal cardiac tissue [109] using onedimension-
al ﬁber simulations. They showed how enhanced coupling increases
electrotonic interactions between cells, decreasing transmural disper-
sion of repolarization (TDR) with respect to control and increasing con-
duction velocity (narrower QRS). On the other hand, slow conduction
and increased APD dispersion results from reduced coupling. They
concluded that slow conduction overrides the intrinsic repolarization
differences in the 3 cell types (endocardial, midmiocardial and epicardi-
al) leading to an inversion of the repolarization sequence and, conse-
quently, inverts membrane potential gradient and the T wave.
Very few studies have simulated cellular uncoupling in the setting of
heart failure. Moreno and coworkers [41] explored the effects of
ﬂecainide and lidocaine on failing myocardium. They calculated single-
cell upstroke velocity and computed the minimum drug concentration
that caused conduction block in one dimensional ﬁber. HF-induced cellu-
lar uncoupling exacerbated arrhythmia susceptibility by markedly
reducing CV. This resulted in conduction block at slower frequencies
and lower concentrations of both ﬂecainide and lidocaine compared to
normal tissue. In the work of Zlochiver and colleagues [32] an analysis
of excitability under HF remodeling was performed. They observed a
non-linear inﬂuence of increased ﬁbroblast to myocyte coupling coefﬁ-
cient on current density thresholds, with an initial increase of current
magnitude followed by a relaxation phase down to the current magni-
tude threshold for the control condition with no ﬁbrosis. In our previous
works, we showed that an intermediate degree of cellular uncoupling in-
creased the vulnerability to reentry of the failing heart and how the de-
gree of cellular coupling could ensure conduction [101,110].
4. In silico analysis of arrhythmias in the failing heart
It is well known that cardiac arrhythmias need a trigger and an elec-
trophysiologically and structurally altered heterogeneous substrate to
be initiated andmaintained. These conditions are fulﬁlled inHF. Electro-
physiological remodeling and altered Ca2+-handling may facilitate
DADs and EADs generation, which may trigger a reentrant arrhythmia
if the myocardial substrate contains repolarization heterogeneities, ﬁ-
brosis and/or uncoupling. This section describes how computational
models have contributed to the understanding of arrhythmogenesis in
the failing heart.
4.1. Triggered activity in HF
It is well known that APD prolongation favors the occurrence of
EADs that are triggered during the plateau phase of an AP and caused
mainly by reactivation of the L-type Ca channels. Ca2+ handling alter-
ations also promote the occurrence of DADs, which are linked to up-
regulation of the NCX in combination with intracellular Ca2+ overload
[2]. But what are the speciﬁc mechanisms underlying EAD and DAD for-
mation in the failing heart? Computational models have been devel-
oped and utilized to elucidate mechanisms of triggered activity in the
setting of HF.
Priebe and Beuckelmann [21] obtained EADs utilizing their HF cellu-
lar model but not the normal physiological model, showing that under
HF remodeling conditions the block of IKr leads to EADs. The inﬂuence
of RyR and L-type calcium channels CaMKII-induced phosphorylation
occurring during HF on EAD generation has also been analyzed in a
computational work by Hashambhoy et al. [27]. They predicted that re-
ducing CaMKII phosphorylation of LCCs may be a more effective ap-
proach to decreasing diastolic SR Ca2+ leak, and thus the likelihood of
EAD generation, than reducing CaMKII phosphorylation of RyRs. Indeed,
the stronger sensitivity of RyR to [Ca2+] in the cytosol than to [Ca2+] inthe SR was responsible for the signiﬁcant decrease of RyR Ca2+ leak
when LCC activity was decreased, and thus [Ca2+] in the cytosol was di-
minished. Trenor et al. showed the important role of an enhanced INaL
on EAD generation in simulated failing cells [35], as suggested experi-
mentally by Maltsev et al. [111]. The results of the simulations showed
that in failingmyocytes, the enhancement of INaL signiﬁcantly prolonged
APD, increasing the probability of ICaL reactivation and initiating EADs.
Similarly, Morita and coworkers [39] simulated the electrical activity
of aging hearts and showed that these hearts are prone to develop
EAD-mediated arrhythmias due to oxidative stress, when INaL is en-
hanced. They concluded that in aged ventricles exposed to oxidative
stress, intermediate levels of ﬁbrosis facilitates the ability of cellular
EADs to emerge and propagate.
Although DADs have beenmeasured experimentally in the setting of
HF [112], very little computationalwork has yet addressed this issue. The
ﬁrst HF computer modeling study by Priebe and Beuckelmann [21]
showed how spontaneous Ca2+ release from the sarcoplasmic reticulum
can trigger a premature action potential in single failing myocytes but
not in normal myocytes, due to a greater INCX. However, DADs are not
likely to trigger a premature beat in the intact heart because the strong
electrotonic coupling between myocytes acts as a sink for local
depolarizing currents. Mathematical models have shown that to over-
come the source-sink mismatch, DADs must occur simultaneously in a
large number of cells. These numbers are signiﬁcantly decreased by re-
duced gap junction conductance, simulated ﬁbrosis, reduced repolariza-
tion reserve, and heart failure electrical remodeling [113]. The beneﬁcial
effects of drugs, such as ranolazine, in reversing the formation of DADs
have also been suggested in a computational study [31] of HF. Applica-
tion of ranolazine blocks INaL and normalizes the increased [Na+]i levels
and the slowed inward NCX current. This allows a normalized Ca2+ ex-
trusion through NCX abolishing the spontaneous Ca2+ transients that
lead to DADs. Ranolazine also hyperpolarizes the resting membrane po-
tential, thus elevating the threshold for triggered diastolic events. Com-
puter simulations add value and provide insights into arrhythmogenic
mechanisms testing different hypotheses that the experimental ap-
proach cannot assess or would imply an elevated time and resources de-
mand. Computational approach complements experimental studies by
showing how HF-induced alterations favor the occurrence of triggered
activity and also provide the substrate for arrhythmia maintenance.
4.2. Altered substrate in HF
Arrhythmogenic processes develop in pathological cardiac tissues
with altered biomarkers, such as repolarization gradients, restitution
curves or conduction velocity. An important feature of diseased tissues
is the presence of increased electrophysiological gradients, which
favor the maintenance of reentrant rhythms. An increase of transmural
dispersion of repolarization (TDR) has been identiﬁed in the failing ca-
nine heart [114], and was attributed to a pronounced APD prolongation
in M cells. Enhanced gradients were directly responsible for develop-
ment of functional conduction block, leading to polymorphic ventricular
tachycardia. In the human right ventricle, Lou et al. [115] also observed
an increase in APD gradients in HF using optical mapping technique and
related it to the increased arrhythmogenesis they observed. In contrast,
Coronel et al. [116] observed that in the pig ventricle it is not only the
repolarization gradient but also the restitution characteristics in combi-
nationwith the timeof arrival of theprematurewavefront,whichdeter-
mines the occurrence of conduction block and reentry. Furthermore,
recent experiments have shown that TDR and APD gradients are re-
duced in human HF [117,118]. In these failing tissues no M cells were
found. Thus, complex and sometimes controversial alterations of the
electrophysiological properties have been observed in the failing tissue
so that arrhythmogenic mechanisms remain poorly understood. This is
where computational studies are of great help by performingmechanis-
tic analyses using mathematical models of disease-speciﬁc APs in the
human heart, and revealing mechanisms for arrhythmogenesis. In this
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sion under HF conditions assuming transmural homogeneous ion
channel remodeling with respect to control, regardless of the presence
or absence of M cells, but decreased TDR values were found when
transmural heterogeneous remodeling was considered [53] and only
in the absence of M cells. This computational study explained the
above mentioned experimental controversial ﬁndings for TDR in HF,
showing that the absence of M cells in the human failing heart is impor-
tant but not sufﬁcient to bring TDR values below those of nonfailing
hearts. Heterogeneous remodeling of ion channels through the ventric-
ular wall has a crucial role in the decrease of repolarization gradients in
HF. Also the presence or absence of ﬁbrosis in experimentally analyzed
cardiac tissues can signiﬁcantly change TDR measurements, as shown
by Gomez et al. who demonstrated computationally that the presence
of ﬁbrosis and cellular uncoupling increased repolarization gradients
[53].
APD restitution gives information on APD adaptation to selected
pacing rhythms. Glukhov et al. [117] obtained a smaller slope of the res-
titution curve in the failing human heart than in normal donor hearts.
Different results were obtained by the computational study of Elshrif
et al. [119], where restitution curves were steeper in virtual failing
cells than in normal cells using the O'Hara et al. human AP model [52].
Further simulation studies would be very valuable to enrich our under-
standing of the relationship between this biomarker and arrhythmias in
the setting of HF.
Computational simulation studies have also aimed to provide in-
sights into ionic mechanisms underlying the occurrence of alternans
[120–122]. Much emphasis has been placed on the restitution curve
slope as a major factor in the onset of arrhythmias following the devel-
opment of discordant alternans where ﬂattening the APD restitution
curve is predicted to inhibit alternans development and subsequent
conduction block [123]. Walmsley et al. [37] suggested that alternans
are due to different causes in the failing population versus non-failing
population cellular models. Their results showed that alternans are pri-
marily favored by low values of IKr conductance in failing human
cardiomyocytes and by reduced SERCA pump and enhanced ICaL con-
ductance in non-failing human cardiomyocytes. This is a ﬁrst step to-
wards clinical translation from disease modeling.
A reduction in conduction velocity (CV) has been measured experi-
mentally in the failing human heart [108]. Loss of gap junction proteins
in the intercalated disk and interactionwithﬁbroblasts give rise to alter-
ations in conduction velocity. In this regard, several works studied how
the percentage of ﬁbrotic content alters normal wave propagation [53,
95,103,124,125]. Nayak and coworkers [102] calculated that the
plane-wave conduction velocity CVdecreases as a function of intercellu-
lar coupling between myocytes and ﬁbroblast (Ggap), for zero-sided
and one-sided couplings; however, for two-sided coupling, CV de-
creases initially and then increases as a function of Ggap. In other simu-
lation study, Majumder and coworkers [103] showed in 2D domains
with a random distribution of ﬁbroblasts in a myocyte background
that as the percentage of ﬁbroblasts increases, the CV of a plane wave
decreases, slowly at ﬁrst and rapidly thereafter, until it reaches zero
and there is conduction failure.
4.3. Reentrant arrhythmias in HF
Changes inmyocardial structure, includingmicroanatomy, in combi-
nationwith the electrophysiological remodeling in the failing heart pro-
mote arrhythmias. Generation of triggered activity helps to initiate
arrhythmias and an altered substrate contributes to arrhythmiamainte-
nance. Reduced excitability at the cellular level emerges in coupled tis-
sue as a slowing of conduction velocity of the propagating depolarizing
wave. Furthermore, repolarization gradients and electrophysiological
heterogeneity favor unidirectional block and reentry. To generate reen-
trant circuits, an excitable gap or a vulnerable window (VW) is required
[2], and slow conduction and heterogeneities widen the VW.Several simulation studies have modeled structural alterations ob-
served in HF to reproduce reentrant activity. The importance of ﬁbrosis
in determining the dynamics and stability of reentry has been highlight-
ed in several computational studies. Majumder and coworkers [103]
characterized spiral wave dynamics depending on ﬁbroblast content.
As the percentage of ﬁbroblasts increases, spiral wave dynamics was
characterized in a variety of nonequilibrium states, (temporally periodic,
quasiperiodic, chaotic and quiescent) and an intricate sequence of transi-
tions between them. Indeed, the electrical coupling of cardiomyocytes
with ﬁbroblasts cells alters the anisotropic action potential propagation
in the human failing heart in a fashion that signiﬁcantly depends on
the density ofﬁbrotic content and on the degree of intercellular coupling.
A range of intermediate levels ofﬁbrosis and intercellular uncoupling can
combine to favor reentrant activity [101].
In order to assess spiral wave dynamics phase maps analysis pro-
vides a powerful tool to explore abnormal conduction patterns in the
setting of ventricular ﬁbrosis. This method is a valuable tool which
helps to identify and quantify spatiotemporal organization of reentry
dynamics [126]. The phase tracks the progression of a deﬁned region
of the myocardium through the action potential. Points around which
the phase progresses through a complete cycle from−π to π are of spe-
cial interest. At these points, the phase becomes indeterminate and the
activation wave fronts hinge on these points and rotate around them in
an organized fashion. These points in the phase map are called phase
singularity points (PS). PS share locationwith anatomic heterogeneities,
and their spatial meandering is modulated by these heterogeneities.
Phase analysis was employed in Gomez et al. (see Fig. 2) [101] and
other studies [127,128]. These studies showed that the presence of
structural heterogeneities, such as ﬁbrosis, increased the number of
phase singularities, and thus the risk of wave break [101,129]. Further-
more, when intermediate levels of ﬁbrosis are considered, the tip of the
reentry meanders within a larger area and the vulnerable window is
wider [101] as illustrated in Fig. 2. Finally, ﬁbrosis seems to have an im-
portant role in the reduction of the rotation frequency of spiral waves.
Simulation studies predicted that the rotation frequency of the spiral
wave slightly decreased with increased ﬁbrosis [99,101,129,130]. Fur-
ther computational research combining structural and electrical remod-
eling [53,101] would be useful to improve our understanding of reentry
mechanisms under failing conditions.
5. Heart failure treatment. Modeling of drug effects and CRT
5.1. Simulation of drug effects in heart failure
Integrative computational simulation has become a powerful tool to
complement experimental and clinical research in multidisciplinary ef-
forts that can elucidate the basic mechanisms of drug effects on ion
channel-mediated phenomena. Pharmaceutical companies have already
suggested the implementation of new testing protocols including the ef-
fects of drugs onmultiple cardiac ion channels and integration of this in-
formation using computational modeling and simulation approaches
[131]. Here we describe some insights given in this direction in the set-
ting of HF. Moreno and coworkers developed a computational model to
simulate the interaction of the anti-arrhythmic drugs ﬂecainide and lido-
cainewith cardiac sodium channels [41] in the failing humanheart. Their
results suggested that lidocaine was less likely than ﬂecainide to pro-
mote reentrant rhythms. Themechanism of this result was also revealed
through a computation component dissection: the slow drug off rate,
which dramatically slows Na channel recovery in the presence of
ﬂecainide was found to promote unidirectional conduction block and
stable reentry. In a different study, Ranolazine was pointed out as an ef-
fective therapeutic strategy against HF due to INaL preferential targeting
[31], as described previously. Further simulation works focusing the ef-
fects of other drugs, such as β-blockers, utilizing a detailed model of HF
would be very useful. Indeed, β-adrenergic stimulation strongly inﬂu-
ences ion channel activity, AP morphology and might contribute to
Fig. 2. Phase map analysis of evoked rhythm disturbances on the failing human ventricular tissue. Phase maps in electrically remodeled failing tissues assuming selected levels of ﬁbrotic
content. The rotor tip trajectory altered by structural heterogeneities. All transient phase singularities are indicated in black, and the tip of the trajectory is indicated in red in the last snap-
shot in each panel.
Reproduced with permission from [101].
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dissect separate effects of the drug on the different cellular targets, while
computer simulations can represent a hypothetic scenario with thou-
sands of possible conﬁgurations.
5.2. Cardiac resynchronization therapy (CRT). Electromechanical approach
Cardiac resynchronization therapy (CRT) is an established therapy
for selected heart failure patients. CRT typically employs bi-ventricular
pacing, with an endocardial right ventricular (RV) pacing lead and an
epicardial left ventricular (LV) pacing lead. It aims to capture RV andLV and thus recoordinate contraction. Simulation approaches can be
used to optimize CRT therapies. For example, seeking for the optimal
pacing timing and location to induce the pacing stimulus helps to obtain
most beneﬁcial regional energy consumption [132]. These studies can
also provide new tools to better discriminate CRT patients. Galeotti
and coworkers [133] increased the speciﬁcity of left bundle branch
block (LBBB) diagnosis in the presence of LV dilation and hypertrophy
by deﬁning new strict LBBB criteria. They developed ﬁve heart models
based on a healthy male with increasing degrees of LV hypertroph
and/or dilation. They simulated six conduction types with each model:
normal conduction, four increments of delayed initiation of LV
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simulated ECGs.
Potse et al. [134] focused on the effects of uncoupling due to LBBB. A
LBBB electrocardiogram type may be caused by either a block in the left
branch of the ventricular conduction system or by uncoupling in the
working myocardium. They used a realistic large-scale computer
model to evaluate the effects of uncoupling with and without left-
sided block. Their simulations showed that uncoupling in the working
myocardium can mimic left-sided block in the ventricular conduction
system and can explain an LBBB ECG pattern with low amplitude.
A three-dimensional computational model of ventricular electro-
mechanics was developed by Usyk and McCulloch [135] to study the
role of biventricular pacing on systolic mechanical performance and syn-
chrony during the cardiac cycle of the dilated failing heart with LBBB.
Their simulations showed that biventricular pacing improves mechanical
synchrony and systolic function. However, experimental studies [136]
suggest that electrical synchrony does not correlate directly with me-
chanical synchrony and systolic performance. Thus, sequential CRT can
improve cardiac performance and mechanical synchrony better than si-
multaneous biventricular pacing [137].
Aiba et al. [138] showed that CRT reduces the frequency of EADs
through INaL decrement, while others studied how geometry and ana-
tomical structures, such as the conduction system, affects pacing in fail-
ing hearts. Rodriguez and coworkers [139] used an anatomically based
rabbit ventricularmodel of electrical stimulation to providemechanistic
insight into the contribution of transmural electrical events in cardiacFig. 3.What can be learnt from computer simulations in heart failure. Multi-scale electromecha
cellular level, electrophysiological remodeling can be modeled by alterations in ion channels,
signiﬁcant changes in action potential and Ca2+ transient waveforms, which might lead to EAD
uncoupling and ﬁbrosis) lead to discontinuous and decreased conduction velocity and electroph
ventricular arrhythmias in the failing heart. Incorporating the mechanical response (electro-m
understanding of the mechanical dysfunction of the failing heart and the design of cardiac resyvulnerability to externally applied shocks and the role of electrode po-
larity change in modulating the mechanisms of reentry induction. The
information provided by the model was critical in understanding the
etiology of shock-induced arrhythmogenesis. Romero and colleagues
[140] used a human heart computer model which incorporated ana-
tomical structures such as myoﬁber orientation and a Purkinje system
(PS) to study how pacing affected failing hearts. Their results showed
that retrograde conduction into the PS was a determining factor for
achieving intraventricular synchrony. Omission of the PS led to an over-
estimate of the degree of electrical dyssynchrony while assessing CRT.
These results should be carefully considered when determining lead
placement and optimizing device parameters in clinical practice.
In this line, patient-speciﬁc models of hearts with contractile
dyssynchrony have been recently developed providing a new clinical
tool in the treatment of dyssynchronous heart failure [141–143].
An important step in computationalmodeling of the heart is the link
between the electrical activity of the myocardium and mechanical con-
traction. Several simulation studies have been undertaken to evaluate
the electromechanical behavior of the heart in selected animal species
but literature is scarce in the setting of human HF [144,145]. The distri-
bution of electromechanical delay (EMD), the time interval between
local depolarization and myocyte shortening onset was analyzed by
Gurev and coworkers [146] in 3D model of the rabbit ventricles during
sinus rhythm and epicardial pacing. Simulations showed a nonuniform
EMD distribution for both conﬁgurations that depends on activation se-
quence and on the pacing rate. Electromechanical simulations based onnical models of heart failure (HF) help to understand arrhythmogenic mechanisms. At the
in β-adrenergic system, and in T-tubules (image taken from [148]) and is responsible for
s and DADs generation. At the tissue and organ level, structural remodeling (intercellular
ysiological heterogeneities. Triggered events and heterogeneous substrate set the stage for
echanical model reproduced with permission from [132]) in a HF model will improve the
nchronization therapy.
156 J.F. Gomez et al. / Journal of Molecular and Cellular Cardiology 89 (2015) 146–159computational models could guide and improve CRT, as in Constantino
et al., who suggested that an adequate pacing locationwould be the site
of longest electromechanical delay [132].
6. Concluding remarks and future challenges
This article reviews the main computational studies on HF from cell
to organ. These studies illustrate how modeling and computer simula-
tions may reveal the mechanisms of arrhythmogenic processes and
therapies in the setting of HF. In this last section, the main advances,
as well as limitations and future challenges of the computational ap-
proach of HF are presented. In addition to the generic limitations of car-
diac models [147], several improvements in the pathological models of
HF should be highlighted to guide research towards future challenges.
As summarized in Fig. 3, simulations at the cellular level have con-
tributed to elucidating the role of ion channel remodeling in AP and
Ca2+ handling HF-induced changes. However, the effects of changes
in the T-tubule system [148] and β-adrenergic pathways in the failing
cell need further analysis. Simulations of AP prolongation and altered
Ca2+ transient have also furthered our understanding of the mecha-
nisms of triggered activity: EADs and DADs in failing cells. 1D, 2D, and
3Dmodels of the failing tissue have made it possible to simulate the ef-
fects of structural remodeling in the failing heart. The increase of cellular
uncoupling and ﬁbrosis in heart failure may have a signiﬁcant role in
setting an arrhythmogenic substrate, leading to cardiac arrhythmias. Al-
though ﬁbroblast interaction with cardiomyocytes has been addressed
in several multi-scale computational studies in normal physiological
conditions, the literature is scarce in the setting of HF. In addition, only
the work of Chilton and coworkers [90] provides experimental data to
inform an electrical model of ventricular ﬁbroblasts. Further experi-
ments are needed to improve these models, such as the work of
Chatelier et al. [149], who reported the expression of voltage gated sodi-
um channels in human atrialﬁbroblasts. Recently a great effort has been
made to improve electromechanical models of the heart, which identify
the link between electrical activity and especially Ca2+ transient and
cellular and organ contraction (see Fig. 3). In terms of HF, electrome-
chanical simulation studies are scarce and further studies are needed.
These computationalmodels can help to evaluatemechanical heart dys-
function and improve CRT.
With regard to drug therapy in HF, apart from several studies focus-
ing on sodium channel blockers, there is a lack of computational work.
The analysis of the effects ofβ-blockers in the failing heart through com-
puter simulations would help to understand why these drugs are effec-
tive in these patients. Recently, safety pharmacology assessments have
highlighted the use of computer simulations in combination with
in vitro experiments on human induced pluripotent stem cell-derived
cardiomyocytes (iPSC-CMs) for drug safety screening. β-blockers have
been proved to improve the function of iPSC-DC from dilated cardiomy-
opathy [150], and because this technology offers the possibility to ob-
tain disease-speciﬁc cell lines, this could also be tested for other HF
etiologies. Furthermore, mathematical models of hiPSC-CMs have
been recently formulated [151], allowing in silico studies for drug safety
and supporting the evaluation of this new in vitro technology [152].
It is important to mention that the efforts recently made in the de-
velopment of patient-speciﬁc models, based on high-resolution images,
will be of great help if they are extended to different stages of HF and
different etiologies.
Finally, a crucial challenge is the integration of computer pathologi-
cal models and simulations into clinical practice. This integration of
computermodels in the clinical routine requires the development of au-
tomatic tools to personalize models and validate them not only in the
laboratory setting but also in a clinical environment, in which clinicians
have to deal with patients with different characteristics. Research effort
needs to be made to build the necessary user-friendly interfaces for cli-
nicians and provide the clinically relevant answers to the speciﬁc ques-
tions of the physicians.Acknowledgements
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